Breaking News Instant updates and real-time market news.

BGNE

BeiGene

$308.27 /

-5.8 (-1.85%)

, MRTX

Mirati Therapeutics

$170.25 /

+3.12 (+1.87%)

18:22
04/11/21
04/11
18:22
04/11/21
18:22

BeiGene presents clinical data on Sitravatinib, Tislelizumab combo

BeiGene (BGNE) announced that clinical data on its anti-PD-1 antibody tislelizumab, in combination with the investigational spectrum-selective kinase inhibitor sitravatinib being jointly developed with Mirati Therapeutics (MRTX), were presented in two oral presentations at the American Association for Cancer Research Annual Meeting 2021. Data presented at the meeting were from two cohorts of a Phase 1b trial, in patients with unresectable or metastatic melanoma who were refractory or resistant to PD-1/L1 inhibitors and in patients with advanced platinum-resistant ovarian cancer. BeiGene has an exclusive collaboration and license agreement with Mirati for the development, manufacturing and commercialization of sitravatinib in Asia - excluding Japan, Australia, and New Zealand. This open-label, multicohort, Phase 1b trial was designed to evaluate safety/tolerability and preliminary antitumor activity of sitravatinib in combination with tislelizumab in advanced solid tumors. The primary endpoint of the trial was safety/tolerability of the combination; key secondary endpoints include investigator-assessed objective response rate, disease control rate, and progression-free survival per RECIST v1.1; overall survival was also assessed. At the time of data cutoff on October 13, 2020, a total of 25 patients with unresectable or metastatic melanoma who were refractory or resistant to anti-PD-1/L1 antibodies and had not received other prior immunotherapy had been enrolled in cohort G of the Phase 1b trial, including 12 with cutaneous subtype, seven with acral subtype, and four with mucosal subtype. At the time of data cutoff, 16 patients remained on study treatment. With a median follow-up time of 5.5 months, results included: All 25 patients experienced at least one treatment-emergent adverse event of any grade; Twelve patients experienced at least one Grade greater than or equal to 3 TEAE; One patient experienced a serious TEAE of anal abscess, associated with sitravatinib; Treatment discontinuation due to TEAEs occurred in two patients, with one discontinuing tislelizumab due to vaginal hemorrhage and the other sitravatinib due to increased BCK; Dose interruptions and reductions of sitravatinib occurred in 18 patients and 13 patients, respectively; All 25 patients were evaluable for efficacy and the confirmed ORR was 24%, including six partial responses, and the disease control rate was 88%; and the media duration of response was not reached, and the investigator-assessed median PFS was 6.7 months. Results in Patients with Advanced PROC include: At the time of data cutoff on October 13, 2020, a total of 60 patients with recurrent PROC who had no prior exposure to anti-PD-1/L1 antibodies had been enrolled in cohort E of the Phase 1b trial and 13 of them remained on study treatment. These patients received a median of four prior regimens. With a median follow-up time of six months, results included: Fifty-eight patients experienced at least one TEAE of any grade; Forty-one patients experienced at least one Grade greater than or equal to 3 TEAE; Forty-two patients experienced at least one serious TEAE; Treatment discontinuation due to TEAEs occurred in 23 patients, with nine patients discontinuing tislelizumab and 14 sitravatinib; Dose interruptions and reductions of sitravatinib occurred in 50 patients and 30 patients, respectively, and dose interruption of tislelizumab occurred in one patient; Four fatal TEAEs were reported, with none considered related to study treatment; Among the 53 patients who were evaluable for efficacy, the confirmed ORR was 26%; The median DoR was 4.7 months; and The median PFS and OS was 4.1 months and 12.9 months, respectively.

BGNE

BeiGene

$308.27 /

-5.8 (-1.85%)

MRTX

Mirati Therapeutics

$170.25 /

+3.12 (+1.87%)

  • 24

    May

  • 18

    Oct

  • 28

    Oct

  • 02

    Dec

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
MRTX Mirati Therapeutics
$170.25 /

+3.12 (+1.87%)

03/01/21 Oppenheimer
Mirati Therapeutics price target lowered to $255 from $260 at Oppenheimer
01/15/21 H.C. Wainwright
Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright
12/08/20 JMP Securities
Mirati Therapeutics initiated with a Market Perform at JMP Securities
11/17/20 BofA
Mirati Therapeutics downgraded to Underperform from Neutral at BofA

TODAY'S FREE FLY STORIES

Hot Stocks
SC Health Corporation (Class A Units) trading halted, volatility trading pause  15:52
05/07/21
05/07
15:52
05/07/21
15:52
 
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 » 15:49
05/07/21
05/07
15:49
05/07/21
15:49
XLRE

Real Estate SPDR

$42.34 /

+0.49 (+1.17%)

, XLY

Consumer Discretionary Sector SPDR

$177.77 /

+1.76 (+1.00%)

, XLK

Technology Select Sector SPDR

$139.19 /

+1.41 (+1.02%)

, XLF

Financial Select Sector

$37.79 /

+0.225 (+0.60%)

, XLE

Energy Select Sector SPDR

$53.66 /

+0.985 (+1.87%)

, XLB

S&P Select Materials SPDR

$87.83 /

+0.81 (+0.93%)

, SPY

SPDR S&P 500 ETF Trust

$422.64 /

+3.56 (+0.85%)

, SPX

S&P 500

/

+

At time of writing the…

At time of writing the S&P 500 was off its session highs but still set to close at a new all-time high. With price last at 4233, there is no resistance overhead. A possible upside range for next week would be 4240-4300. Support is in the range of 4220-4160. The leading sectors for the week were Basic Materials (XLB), Energy (XLE), and the Financials (XLF). On the downside the weakest sectors were Technology (XLK), Consumer Discretionary (XLY), and Real Estate (XLRE).

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLRE Real Estate SPDR
$42.34 /

+0.49 (+1.17%)

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
XLK Technology Select Sector SPDR
$139.19 /

+1.41 (+1.02%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

03/12/21
On The Fly: Weekly technical notes for S&P 500
06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

XLRE Real Estate SPDR
$42.34 /

+0.49 (+1.17%)

XLY Consumer Discretionary Sector SPDR
$177.77 /

+1.76 (+1.00%)

XLK Technology Select Sector SPDR
$139.19 /

+1.41 (+1.02%)

XLF Financial Select Sector
$37.79 /

+0.225 (+0.60%)

XLE Energy Select Sector SPDR
$53.66 /

+0.985 (+1.87%)

XLB S&P Select Materials SPDR
$87.83 /

+0.81 (+0.93%)

SPY SPDR S&P 500 ETF Trust
$422.64 /

+3.56 (+0.85%)

SPX S&P 500
/

+

Hot Stocks
Amazon plans to build first robotics fulfillment center in Louisiana » 15:36
05/07/21
05/07
15:36
05/07/21
15:36
AMZN

Amazon.com

$3,304.00 /

-3 (-0.09%)

Amazon plans to open its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital
04/30/21 Evercore ISI
Amazon price target raised to $4,500 from $4,000 at Evercore ISI
04/30/21 MKM Partners
Amazon.com price target raised to $4,075 from $3,975 at MKM Partners
04/30/21 Raymond James
Amazon.com price target raised to $4,125 from $4,000 at Raymond James
AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

AMZN Amazon.com
$3,304.00 /

-3 (-0.09%)

Options
Univar options imply 8.3% move in share price post-earnings » 15:34
05/07/21
05/07
15:34
05/07/21
15:34
UNVR

Univar

$24.32 /

+0.05 (+0.21%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNVR Univar
$24.32 /

+0.05 (+0.21%)

UNVR Univar
$24.32 /

+0.05 (+0.21%)

03/08/21 BofA
Univar downgraded to Underperform from Buy at BofA
11/06/20 Goldman Sachs
Univar downgraded to Neutral from Buy at Goldman Sachs
UNVR Univar
$24.32 /

+0.05 (+0.21%)

UNVR Univar
$24.32 /

+0.05 (+0.21%)

Recommendations
Standex price target raised to $113 from $110 at Barrington » 15:32
05/07/21
05/07
15:32
05/07/21
15:32
SXI

Standex

$101.80 /

+3.445 (+3.50%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SXI Standex
$101.80 /

+3.445 (+3.50%)

SXI Standex
$101.80 /

+3.445 (+3.50%)

03/01/21 Barrington
Standex price target raised to $110 from $101 at Barrington
02/05/21 Barrington
Standex price target raised to $101 from $97 at Barrington
01/28/21 Barrington
Standex price target raised to $97 from $94 at Barrington
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
SXI Standex
$101.80 /

+3.445 (+3.50%)

SXI Standex
$101.80 /

+3.445 (+3.50%)

Recommendations
Fidus Investment price target raised to $19 from $16 at Raymond James » 15:31
05/07/21
05/07
15:31
05/07/21
15:31
FDUS

Fidus Investment

$17.76 /

+0.36 (+2.07%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDUS Fidus Investment
$17.76 /

+0.36 (+2.07%)

03/01/21 Keefe Bruyette
Fidus upgraded to Outperform after 'strong' 2020 at Keefe Bruyette
03/01/21 B. Riley Securities
Fidus Investment price target raised to $16.50 from $14.50 at B. Riley
03/01/21 Keefe Bruyette
Fidus Investment upgraded to Outperform from Market Perform at Keefe Bruyette
11/24/20 B. Riley Securities
Fidus Investment price target raised to $12 from $10 at B. Riley Securities
FDUS Fidus Investment
$17.76 /

+0.36 (+2.07%)

Recommendations
Peloton price target lowered to $135 from $180 at JMP Securities » 15:27
05/07/21
05/07
15:27
05/07/21
15:27
PTON

Peloton

$84.01 /

+0.21 (+0.25%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

09:28 Today Truist
Peloton price target lowered to $125 from $160 at Truist
08:13 Today Stifel
Peloton price target lowered to $140 from $170 at Stifel
07:55 Today Canaccord
Peloton price target lowered to $150 from $180 at Canaccord
07:53 Today Wedbush
Peloton price target lowered to $114 from $120 at Wedbush
PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

PTON Peloton
$84.01 /

+0.21 (+0.25%)

Conference/Events
VSE Corp. management to meet virtually with Benchmark » 15:26
05/07/21
05/07
15:26
05/07/21
15:26
VSEC

VSE Corp.

$43.72 /

+0.385 (+0.89%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

05/05/21
Fly Intel: Top five analyst initiations
05/05/21 B. Riley
B. Riley starts VSE with Buy, says 'flying under the radar'
05/05/21 B. Riley
VSE Corp. initiated with a Buy at B. Riley
03/19/21 Canaccord
VSE Corp. price target raised to $52 from $48 at Canaccord
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

  • 29
    Jan
VSEC VSE Corp.
$43.72 /

+0.385 (+0.89%)

Conference/Events
Herman Miller participates in a conference call with Benchmark » 15:25
05/07/21
05/07
15:25
05/07/21
15:25
MLHR

Herman Miller

$43.82 /

+0.42 (+0.97%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

09/18/20 Benchmark
Herman Miller price target raised to $40 from $30 at Benchmark
09/17/20 Sidoti
Herman Miller price target raised to $50 from $33 at Sidoti
06/30/20 Sidoti
Herman Miller upgraded to Buy from Neutral at Sidoti
05/22/20 Benchmark
Herman Miller initiated with a Buy at Benchmark
MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

MLHR Herman Miller
$43.82 /

+0.42 (+0.97%)

Recommendations
Immunic price target raised to $56 from $55 at JMP Securities » 15:25
05/07/21
05/07
15:25
05/07/21
15:25
IMUX

Immunic

$12.77 /

+0.9 (+7.58%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMUX Immunic
$12.77 /

+0.9 (+7.58%)

IMUX Immunic
$12.77 /

+0.9 (+7.58%)

04/15/21 Piper Sandler
Piper Sandler 'very encouraged' by Immunic Phase 2 EMPhASIS cohort 2 data
04/15/21 Aegis
Immunic initiated with a Buy at Aegis
03/24/21
Fly Intel: Top five analyst initiations
03/24/21 JMP Securities
Immunic initiated with an Outperform at JMP Securities
  • 05
    Aug
  • 10
    Jun
IMUX Immunic
$12.77 /

+0.9 (+7.58%)

Recommendations
Granite Point Mortgage price target raised to $14 from $13 at JMP Securities » 15:23
05/07/21
05/07
15:23
05/07/21
15:23
GPMT

Granite Point Mortgage

$13.27 /

+0.22 (+1.69%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPMT Granite Point Mortgage
$13.27 /

+0.22 (+1.69%)

GPMT Granite Point Mortgage
$13.27 /

+0.22 (+1.69%)

04/26/21 JPMorgan
Granite Point Mortgage price target raised to $12 from $10 at JPMorgan
Recommendations
Carvana price target raised to $326 from $290 at JMP Securities » 15:21
05/07/21
05/07
15:21
05/07/21
15:21
CVNA

Carvana

$250.50 /

-12.83 (-4.87%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

05/03/21
Fly Intel: Top five analyst upgrades
05/03/21 BofA
Carvana upgraded to Buy at BofA amid tighter new auto supply
05/03/21 BofA
Carvana upgraded to Buy from Neutral at BofA
04/07/21 Raymond James
Carvana initiated with a Market Perform at Raymond James
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

  • 02
    Dec
  • 19
    May
CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

CVNA Carvana
$250.50 /

-12.83 (-4.87%)

Options
McEwen Mining options imply 14.9% move in share price post-earnings » 15:19
05/07/21
05/07
15:19
05/07/21
15:19
MUX

McEwen Mining

$1.30 /

+0.05 (+4.00%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

09/29/20 Alliance Global Partners
McEwen Mining transferred with a Buy at Alliance Global Partners
09/14/20 Roth Capital
McEwen Mining resumed with a Buy at Roth Capital
MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

MUX McEwen Mining
$1.30 /

+0.05 (+4.00%)

Technical Analysis
NASDAQ market internals summary » 15:17
05/07/21
05/07
15:17
05/07/21
15:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 15:16
05/07/21
05/07
15:16
05/07/21
15:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

General news
U.S. consumer credit rose $25.8 B in March » 15:15
05/07/21
05/07
15:15
05/07/21
15:15
$ECON

Economic Data

/

+

U.S. consumer credit rose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Conference/Events
    Hubbell participates in a conference call with Stephens » 15:10
    05/07/21
    05/07
    15:10
    05/07/21
    15:10
    HUBB

    Hubbell

    $199.77 /

    -0.04 (-0.02%)

    Conference call with CEO…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    10/27/20 Stephens
    Hubbell price target raised to $180 from $175 at Stephens
    10/15/20 Stephens
    Hubbell resumed with an Overweight at Stephens
    09/15/20 UBS
    Hubbell initiated with a Neutral at UBS
    HUBB Hubbell
    $199.77 /

    -0.04 (-0.02%)

    Conference/Events
    Kirby management to meet virtually with Stephens » 15:09
    05/07/21
    05/07
    15:09
    05/07/21
    15:09
    KEX

    Kirby

    $67.67 /

    +0.67 (+1.00%)

    Virtual Meeting to be…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    09:30 Today Gabelli
    Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
    08:38 Today Gabelli
    Kirby downgraded to Hold from Buy at Gabelli
    11/18/20 BofA
    Kirby upgraded to Buy at BofA on refinery utilization increase potential
    11/18/20 BofA
    Kirby upgraded to Buy from Neutral at BofA
    KEX Kirby
    $67.67 /

    +0.67 (+1.00%)

    General news
    March consumer credit up $25.8B vs. last month, consensus $17.7B  15:08
    05/07/21
    05/07
    15:08
    05/07/21
    15:08
    $ECON

    Economic Data

    /

    +

     
    ShowHide Related Items >><<
      Options
      U S Global Investors options imply 10.6% move in share price post-earnings » 15:04
      05/07/21
      05/07
      15:04
      05/07/21
      15:04
      GROW

      U.S. Global Investors

      $7.38 /

      +0.165 (+2.29%)

      Pre-earnings options…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      GROW U.S. Global Investors
      $7.38 /

      +0.165 (+2.29%)

      On The Fly
      Short Interest Report: Bearish positioning on Washington Federal, iRobot jump » 14:59
      05/07/21
      05/07
      14:59
      05/07/21
      14:59
      WAFD

      Washington Federal

      $33.02 /

      -0.15 (-0.45%)

      , IRBT

      iRobot

      $96.56 /

      -1.86 (-1.89%)

      , MVIS

      MicroVision

      $14.14 /

      +0.14 (+1.00%)

      , M

      Macy's

      $17.61 /

      +0.285 (+1.65%)

      , DAC

      Danaos

      $64.70 /

      +1.43 (+2.26%)

      , PGEN

      Precigen

      $6.52 /

      -0.08 (-1.21%)

      , BRN

      Barnwell Industries

      $2.88 /

      -0.12 (-4.00%)

      , IWF

      iShares Russell 1000 Growth

      $256.38 /

      +1.39 (+0.55%)

      , IWD

      iShares Russell 1000 Value

      $161.70 /

      +1.19 (+0.74%)

      Welcome to this week’s…

      ShowHide Related Items >><<
      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      02/12/21 Northland
      iRobot price target raised to $140 from $120 at Northland
      02/12/21 Citi
      iRobot price target raised to $140 from $95 at Citi
      02/11/21 JPMorgan
      iRobot upgraded to Overweight from Neutral at JPMorgan
      02/11/21 JPMorgan
      iRobot upgraded to Overweight from Neutral at JPMorgan
      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      04/19/21 JPMorgan
      Macy's price target raised to $16 from $15 at JPMorgan
      03/12/21 Jefferies
      Jefferies picks Macy's, Kohl's and Nordstrom as department store 'survivors'
      02/24/21 Credit Suisse
      Macy's price target raised to $13 from $7 at Credit Suisse
      02/24/21 Deutsche Bank
      Macy's price target raised to $16 from $15 at Deutsche Bank
      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      03/29/21 Fearnley
      Danaos initiated with a Buy at Fearnley
      12/09/20 Jefferies
      Danaos price target raised to $18 from $13 at Jefferies
      09/28/20 Citi
      Danaos price target raised to $6.25 from $4.75 at Citi
      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      03/02/21 B. Riley Securities
      Precigen price target raised to $14 from $10 at B. Riley Securities
      02/25/21 Stifel
      Precigen initiated with a Buy at Stifel
      02/22/21 Wells Fargo
      Precigen initiated with an Overweight at Wells Fargo
      02/18/21
      Fly Intel: Top five analyst initiations
      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      IWF iShares Russell 1000 Growth
      $256.38 /

      +1.39 (+0.55%)

      IWD iShares Russell 1000 Value
      $161.70 /

      +1.19 (+0.74%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      • 22
        Jan
      • 24
        Nov
      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      BRN Barnwell Industries
      $2.88 /

      -0.12 (-4.00%)

      IWF iShares Russell 1000 Growth
      $256.38 /

      +1.39 (+0.55%)

      IWD iShares Russell 1000 Value
      $161.70 /

      +1.19 (+0.74%)

      WAFD Washington Federal
      $33.02 /

      -0.15 (-0.45%)

      IRBT iRobot
      $96.56 /

      -1.86 (-1.89%)

      MVIS MicroVision
      $14.14 /

      +0.14 (+1.00%)

      M Macy's
      $17.61 /

      +0.285 (+1.65%)

      DAC Danaos
      $64.70 /

      +1.43 (+2.26%)

      PGEN Precigen
      $6.52 /

      -0.08 (-1.21%)

      Recommendations
      Tabula Rasa price target raised to $45 from $41 at Piper Sandler » 14:49
      05/07/21
      05/07
      14:49
      05/07/21
      14:49
      TRHC

      Tabula Rasa HealthCare

      $47.06 /

      +4.89 (+11.60%)

      Piper Sandler analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      03/01/21
      Fly Intel: Top five analyst downgrades
      03/01/21 Truist
      Tabula Rasa HealthCare downgraded to Hold from Buy at Truist
      03/01/21 Truist
      Tabula Rasa HealthCare downgraded to Hold from Buy at Truist
      02/24/21 Piper Sandler
      Tabula Rasa HealthCare downgraded to Neutral from Overweight at Piper Sandler
      TRHC Tabula Rasa HealthCare
      $47.06 /

      +4.89 (+11.60%)

      Options
      Denison Mines options imply 6.4% move in share price post-earnings » 14:49
      05/07/21
      05/07
      14:49
      05/07/21
      14:49
      DNN

      Denison Mines

      $1.17 /

      +0.005 (+0.43%)

      Pre-earnings options…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      DNN Denison Mines
      $1.17 /

      +0.005 (+0.43%)

      DNN Denison Mines
      $1.17 /

      +0.005 (+0.43%)

      03/24/21 Raymond James
      Denison Mines price target raised to C$1.70 from C$1.20 at Raymond James
      02/25/21 TD Securities
      Denison Mines price target raised to C$1.55 from C$1 at TD Securities
      02/10/21 Raymond James
      Denison Mines price target raised to C$1.20 from C$1.15 at Raymond James
      01/21/21 Canaccord
      Denison Mines price target raised to C$1.10 from C$0.90 at Canaccord
      DNN Denison Mines
      $1.17 /

      +0.005 (+0.43%)

      Recommendations
      Intel should regain industry leadership via investments, says Tigress Financial » 14:48
      05/07/21
      05/07
      14:48
      05/07/21
      14:48
      INTC

      Intel

      $57.54 /

      +0.36 (+0.63%)

      Tigress Financial analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      05/04/21 Stifel
      Intel spending plans show new CEO 'gets it,' says Stifel
      04/29/21 Needham
      MaxLinear price target raised to $50 from $45 at Needham
      04/23/21 Needham
      Intel price target lowered to $70 from $74 at Needham
      04/23/21 Morgan Stanley
      Intel report offered 'no big surprises,' says Morgan Stanley
      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      INTC Intel
      $57.54 /

      +0.36 (+0.63%)

      Options
      Bridgetown Holdings call volume above normal and directionally bullish » 14:45
      05/07/21
      05/07
      14:45
      05/07/21
      14:45
      BTWN

      Bridgetown Holdings

      $10.15 /

      -0.04 (-0.39%)

      Bullish option flow…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      BTWN Bridgetown Holdings
      $10.15 /

      -0.04 (-0.39%)

      BTWN Bridgetown Holdings
      $10.15 /

      -0.04 (-0.39%)

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.